| Autor: |
Nana P; German Aortic Center, Department of Vascular Medicine, University Heart and Vascular Center UKE Hamburg, 20246 Hamburg, Germany., Panuccio G; German Aortic Center, Department of Vascular Medicine, University Heart and Vascular Center UKE Hamburg, 20246 Hamburg, Germany., Rohlffs F; German Aortic Center, Department of Vascular Medicine, University Heart and Vascular Center UKE Hamburg, 20246 Hamburg, Germany., Torrealba JI; German Aortic Center, Department of Vascular Medicine, University Heart and Vascular Center UKE Hamburg, 20246 Hamburg, Germany., Spanos K; German Aortic Center, Department of Vascular Medicine, University Heart and Vascular Center UKE Hamburg, 20246 Hamburg, Germany., Kölbel T; German Aortic Center, Department of Vascular Medicine, University Heart and Vascular Center UKE Hamburg, 20246 Hamburg, Germany. |
| Abstrakt: |
Background : Among the endovascular approaches for the management of endoleak type 2 (EL 2), transcaval embolization (TCE) has shown encouraging outcomes. However, the literature is still limited. This study aimed to present the early and mid-term outcomes of TCE for EL 2 after endovascular aortic repair. Methods : A retrospective, single-center analysis of consecutive patients managed with TCE for EL 2 after standard or complex endovascular aortic repair, from August 2015 to March 2024, was conducted. The indication for TCE was the presence of an EL 2 related to ≥5 mm sac increase, compared to the first imaging after aneurysm exclusion or the smallest diameter during follow-up. Patients managed with TCE for other types of endoleaks were excluded. The primary outcomes were technical and clinical successes during follow-up. Results: Forty-three patients were included (mean age: 75.1 ± 6.0 years, 90.7% males). Technical success was 97.7%. Selective embolization was performed in 48.8% and non-selective in 51.2%. No death was recorded at 30 days. The estimated clinical success was 90.0% (standard error; SE: 6.7%) and the freedom from EL 2 was 89.0% (SE 6.4%) at 36 months. Cox regression analysis showed that the type of embolization (selective vs. non-selective), type of previous repair (f/bEVAR vs. EVAR), and use of anticoagulants did not affect follow-up outcomes. Reinterventions related to EL 2 were performed in 12.5%; three underwent an open conversion. Conclusions : TCE was related to high technical success and limited peri-operative morbidity, regardless of the type of initial endovascular aortic repair. Clinical success was encouraging with reinterventions for EL 2 affecting 12.5% of patients. |
